Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pariente
Edouard Louis

Showing results (131-140 of 364) with videos related to

Pageof 37
Sort By:
International Journal of Molecular Sciences|October 16, 2024
A Synbiotic Combining Chitin-Glucan and <i>Lactobacillus acidophilus</i> NCFM Induces a Colonic Molecular Signature Soothing Intestinal Pain and Inflammation in an Animal Model of IBSLena Capirchio, Christel Rousseaux, Caroline Dubuquoy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 14, 2015
Changes in the Lémann Index Values During the First Years of Crohn's DiseaseCyrielle Gilletta, Maïté Lewin, Anne Bourrier, et al.
Food Research International (Ottawa, Ont.)|March 22, 2024
Food additives impair gut microbiota from healthy individuals and IBD patients in a colonic in vitro fermentation modelIrma Gonza, Elizabeth Goya-Jorge, Caroline Douny, et al.
Rheumatology (Oxford, England)|September 6, 2011
Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug useJohanna M W Hazes, Pierre G Coulie, Vincent Geenen, et al.
Journal of Crohn'S & Colitis|June 9, 2021
Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative ColitisSubrata Ghosh, Yuri Sanchez Gonzalez, Wen Zhou, et al.
Rheumatology (Oxford, England)|July 2, 2010
Vaccinations in patients with immune-mediated inflammatory diseasesJean-François Rahier, Michel Moutschen, Alfons Van Gompel, et al.
Journal of Crohn'S & Colitis|April 7, 2012
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trialEdouard Louis, Robert Löfberg, Walter Reinisch, et al.
International Journal of Colorectal Disease|November 26, 2016
Post-operative recurrence of Crohn's disease after definitive stoma: an underestimated riskDine Koriche, Corinne Gower-Rousseau, Charbel Chater, et al.
Alimentary Pharmacology & Therapeutics|March 30, 2020
Bowel damage and disability in Crohn's disease: a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability IndexClémentine Lauriot Dit Prevost, Mustapha Azahaf, Maria Nachury, et al.
Journal of Crohn'S & Colitis|September 2, 2021
Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: A Phase I-II Clinical StudySophie Vieujean, Jean-Philippe Loly, Layla Boutaffala, et al.
Pageof 37

Showing results (131-140 of 364) with videos related to

Sort By:
Pageof 37
International Journal of Molecular Sciences|October 16, 2024
A Synbiotic Combining Chitin-Glucan and <i>Lactobacillus acidophilus</i> NCFM Induces a Colonic Molecular Signature Soothing Intestinal Pain and Inflammation in an Animal Model of IBSLena Capirchio, Christel Rousseaux, Caroline Dubuquoy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 14, 2015
Changes in the Lémann Index Values During the First Years of Crohn's DiseaseCyrielle Gilletta, Maïté Lewin, Anne Bourrier, et al.
Food Research International (Ottawa, Ont.)|March 22, 2024
Food additives impair gut microbiota from healthy individuals and IBD patients in a colonic in vitro fermentation modelIrma Gonza, Elizabeth Goya-Jorge, Caroline Douny, et al.
Rheumatology (Oxford, England)|September 6, 2011
Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug useJohanna M W Hazes, Pierre G Coulie, Vincent Geenen, et al.
Journal of Crohn'S & Colitis|June 9, 2021
Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative ColitisSubrata Ghosh, Yuri Sanchez Gonzalez, Wen Zhou, et al.
Rheumatology (Oxford, England)|July 2, 2010
Vaccinations in patients with immune-mediated inflammatory diseasesJean-François Rahier, Michel Moutschen, Alfons Van Gompel, et al.
Journal of Crohn'S & Colitis|April 7, 2012
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trialEdouard Louis, Robert Löfberg, Walter Reinisch, et al.
International Journal of Colorectal Disease|November 26, 2016
Post-operative recurrence of Crohn's disease after definitive stoma: an underestimated riskDine Koriche, Corinne Gower-Rousseau, Charbel Chater, et al.
Alimentary Pharmacology & Therapeutics|March 30, 2020
Bowel damage and disability in Crohn's disease: a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability IndexClémentine Lauriot Dit Prevost, Mustapha Azahaf, Maria Nachury, et al.
Journal of Crohn'S & Colitis|September 2, 2021
Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: A Phase I-II Clinical StudySophie Vieujean, Jean-Philippe Loly, Layla Boutaffala, et al.
Pageof 37